Overexpression of JAM-A in Non-Small Cell Lung Cancer Correlates with Tumor Progression

Low Expression of Junctional Adhesion Molecule A Is Associated with Metastasis and Poor Survival in Pancreatic Cancer

(2012) Dominic Fong et al.   ANNALS OF SURGICAL ONCOLOGY

A novel role for junctional adhesion molecule-A in tumor proliferation: Modulation by an anti-JAM-A monoclonal antibody

(2012) Liliane Goetsch et al.   INTERNATIONAL JOURNAL OF CANCER

Junctional adhesion molecule-A is co-expressed with HER2 in breast tumors and acts as a novel regulator of HER2 protein degradation and signaling

(2012) K Brennan et al.   ONCOGENE

JAM-A regulates epithelial proliferation through Akt/β-catenin signalling

(2011) Porfirio Nava et al.   EMBO REPORTS

Abrogation of Junctional Adhesion Molecule-A Expression Induces Cell Apoptosis and Reduces Breast Cancer Progression

(2011) Masato Murakami et al.   PLoS One

Junctional Adhesion Molecule

(2010) Hisato Koshiba et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

miR-145-dependent targeting of Junctional Adhesion Molecule A and modulation of fascin expression are associated with reduced breast cancer cell motility and invasiveness

(2010) M Götte et al.   ONCOGENE

JAM-A expression positively correlates with poor prognosis in breast cancer patients

(2009) Elaine A. McSherry et al.   INTERNATIONAL JOURNAL OF CANCER

Junctional Adhesion Molecule A Interacts with Afadin and PDZ-GEF2 to Activate Rap1A, Regulate β1 Integrin Levels, and Enhance Cell Migration

(2009) Eric A. Severson et al.   MOLECULAR BIOLOGY OF THE CELL

Attenuation of Junctional Adhesion Molecule-A Is a Contributing Factor for Breast Cancer Cell Invasion

(2008) M. U. Naik et al.   CANCER RESEARCH